Genalyte
Lab results in under 30 minutes, right in your clinic.
San Diego, United States · Founded 2007 · $164.8M raised
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- genalyte.com
- Total Funding
- $164.8M
- Last Round
- $67.0M Series CMar 2023
- Rounds
- 4
About
Genalyte builds point-of-care lab testing systems that deliver 90% of clinical lab results in under 30 minutes without leaving the clinic. Its flagship Merlin platform is a fully automated, onsite blood testing machine using silicon photonic microring sensor technology. The company submitted the Merlin device to the FDA for premarket clearance in 2025 and is part of the MedTech Innovator accelerator.
Summary
Genalyte is a Biotech company based in San Diego, United States, founded in 2007. It has raised $164.8M in total across 4 rounds, most recently a $67.0M Series C round in Mar 2023. Investors include Verily Life Sciences, Boutique Venture Partners and Khosla Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2023
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company